ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

Related Keywords

Canada ,Dublin ,Ireland ,Canadian , ,Prnewswire Endo International ,Branded Pharmaceuticals ,Paladin Labs Inc ,Linkedin ,Company Net Debt Leverage Ratio ,Generic Pharmaceuticals ,Endo Investor Relations Department ,Nasdaq ,Exchange Commission ,International Pharmaceuticals ,Pfizer Inc ,Endo International ,Company Loss ,Months Ended June ,Diluted Net ,Diluted Net Income ,Continuing Operations ,Diluted Weighted Average Shares ,Adjusted Income ,Weighted Average Shares ,Adjusted Diluted Net Income ,Sterile Injectables ,Nasal Spray ,Paladin Labs ,Condensed Consolidated Statement ,Condensed Consolidated Balance Sheet ,Cash Flow ,Qualified Settlement ,Current Report ,Supplemental Financial Information ,Condensed Consolidated Statements ,Net Debt Leverage Ratio ,Net Debt ,Restricted Cash ,Net Debt Leverage ,Debt Leverage Ratio ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Endo International Plc ,